ACTEMRA® is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA® is used to treat adults with moderately to severly active active rheumatoid arthritis (RA) after at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well. It is given as a monthly IV infusion.
For more information about ACTEMRA®, please visit www.actemra.com
BENLYSTA®is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines
For more information about BENLYSTA®, please visit www.benlysta.com
Boniva is a prescription medicine used to treat or prevent osteoporosis in women after menopause. Boniva helps increase bone mass and helps reduce the chance of having a spinal fracture (break).
For more information, please visit: www.boniva.com
CIMZIA® (certolizumab pegol) is an exciting new option in RA therapy which in clinical trial has been shown to reduce pain, stiffness and fatigue as fast as 1 to 2 weeks. Many patients on CIMZIA® experienced lasting relief at both 6 months and 1 year.
CIMZIA® is a medicine used to treat adults with moderately to severely active Rheumatoid Arthritis and is also approved for Crohn’s disease.
CIMZIA® is referred to as an “anti-TNF therapy”. By blocking tumor necrosis factor (TNF)-alpha, CIMZIA® helps reduce the inflammation, stiffness and joint damage RA causes.
CIMZIA® is taken by an injection under the skin. After initial doses, CIMZIA® can be injected every 2 or 4 weeks and may be taken with or without other RA medications like methotrexate.
For more information about CIMZIA®, please visit www.cimzia.com
Joint pain and inflammation can limit your abilities from washing your hair to finishing a project at work. In fact, scientists have studied and identified the impact an illness such as rheumatoid arthritis can have on a person’s health-related quality of life in specific areas. Researchers have assessed these areas using a survey called the SF-36®. The SF-36® asks 36 questions in 8 areas of function about physical and mental aspects of an individual’s health-related quality of life. ORENCIA® has been shown to improve the signs and symptoms of rheumatoid arthritis, slow the advance of joint damage, and help improve physical function.
Read more about ORENCIA® at www.orencia.com
Prolia® (denosumab) is a different way to treat postmenopausal osteoporosis in women who have an increased risk for fractures. Prolia is one shot, given in your doctor’s office every 6 months, that can help reduce fracture risk and strengthen your bones.
For more information about Prolia®, please visit www.prolia.com
Maintaining your bone health can help you stay strong for your family, friends and the other parts of your active life. Just one annual dose of Reclast, along with daily calcium and Vitamin D, helps to increase your bone density. So your bones can be stronger and better protected.
For more information, please visit the Reclast® webpage.
When taken with methotrexate, REMICADE® can provide quick symptom relief—in as few as 2 weeks for some patients. Of course, the potential impact of RA goes beyond your day-to-day symptoms. So it’s good to know that REMICADE® can also help stop the progression of long-term damage. Individual results may vary.
Read more about REMICADE® at www.remicade.com
RITUXAN® (rituximab) is a monoclonal antibody used in adults with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after at least one other medicine called a tumor necrosis factor (TNF) inhibitor has not been effective. It is also approved for Granulomatosis with Polyangiitis (GPA or Wegeners) and Microscopic Polyangiitis (MPA), Non-Hodgkins Lymphoma and certain leukemias.
Read more about RITUXAN® at www.rituxan.com
XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.
Read more about XELJANZ at www.xeljanz.com